
Science · Health
US drug regulator expects mifepristone report by March 2027
The safety study is expected to finish by mid-December 2026. The progress update announces no new prescribing restriction.
2 min

The safety study is expected to finish by mid-December 2026. The progress update announces no new prescribing restriction.
2 min
26 articles
























